Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19
Emiko Desvaux(Inserm), Philippe Moingeon(Servier (France)), Antoine Hamon(Laboratoire Vision Action Cognition), Pierre Jean-François(Servier (France)), Cheïma Boudjeniba(Institut Pasteur), Jack Swindle(Laboratoire Vision Action Cognition), Perrine Soret(Servier (France)), Isabelle Dupin‐Roger(Servier (France)), Audrey Aussy(Servier (France)), Jessica Laplume(Servier (France)), Laurence Laigle(Servier (France)), Mickaël Guedj(Servier (France)), Bastien Chassagnol(Servier (France)), Sandra Hubert(Servier (France))
Cited by 18
Related Papers
A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome
|Nature Communications|2021|166
Gaussian Mixture Models in R
|The R Journal|2023|10
Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjögren's disease
|Clinical Immunology|2024|2